会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Pheophorbide derivatives and alkaline salts thereof
    • 偏硼酸衍生物及其碱式盐
    • US4709022A
    • 1987-11-24
    • US746386
    • 1985-06-19
    • Isao SakataSusumu NakajimaKoichi KoshimuziNatsuki SamejimaKazumi InoharaHiroyuki Takata
    • Isao SakataSusumu NakajimaKoichi KoshimuziNatsuki SamejimaKazumi InoharaHiroyuki Takata
    • A61K31/40A61P35/00C07D487/22C07D519/00
    • C07D487/22C07D519/00
    • Pheophorbide derivatives and alkaline salts thereof having the general formula (A): ##STR1## wherein R.sub.1 represents --CH.dbd.CH.sub.2, --CH(OH)CH.sub.3, --CH(OCH.sub.2 CH.sub.2 OH)CH.sub.3 or --CH(OCOCH.sub.3)CH.sub.3R.sub.2 represents --CH.sub.3, --CHO or --CH.sub.2 OHR.sub.3 represents .dbd.O, --OH or --OCOCH.sub.3R.sub.4 represents --H, --COOCH.sub.3, --COOCH.sub.2 CH.sub.2 OH, --COOCH.sub.2 CH.sub.2 OCOCH.sub.3, or a --CONH-- containing residue of an amino acid andR.sub.5 represents --COOH, --COONa or --COOCH.sub.3 ; provided, however, said derivatives and alkaline salts exclude pheophorbide, 9-desoxo-9-hydroxy-pheophorbide and pyropheophorbide.Dimeric pheophorbide derivatives and alkaline salts thereof represented by the general formula (B): ##STR2## wherein R.sub.1 through R.sub.5 are the same as in general formula (A), are useful for treating cancer having a strong preferential affinity for cancer cells over normal cells and exerting upon irradiation a destructive effect on such cancer cells.
    • (A)的焦磷酸衍生物及其碱金属盐:其中R 1表示-CH = CH 2,-CH(OH)CH 3,-CH(OCH 2 CH 2 OH)CH 3或-CH(OCOCH 3) -CH 3,-CHO或-CH 2 OH R 3表示= O,-OH或-OCOCH 3 R 4表示-H,-COOCH 3,-COOCH 2 CH 2 OH,-COOCH 2 CH 2 OCOCH 3或含-CONH-的氨基酸残基,R 5表示-COOH, COONa或-COOCH3; 但是,所述衍生物和碱性盐不包括偏硼酸,9-脱氧-9-羟基 - 脱镁叶绿素和焦脱镁叶绿素。 由通式(B)表示的二聚偏硼酸衍生物及其碱式盐:其中R 1至R 5与通式(A)中相同)可用于治疗对癌细胞具有强的优先亲和力的癌症 超过正常细胞,并在照射下施加对这种癌细胞的破坏作用。
    • 2. 发明授权
    • Porphyrin derivatives
    • 卟啉衍生物
    • US4849207A
    • 1989-07-18
    • US922492
    • 1986-10-23
    • Isao SakataSusumu NakajimaKoichi KoshimizuNatsuki SamejimaKazumi InoharaHiroyuki TakataHirohiko YamauchiNobuo UedaMasaaki Hazue
    • Isao SakataSusumu NakajimaKoichi KoshimizuNatsuki SamejimaKazumi InoharaHiroyuki TakataHirohiko YamauchiNobuo UedaMasaaki Hazue
    • A61K31/40A61K31/43C07B59/00C07D487/22
    • C07D487/22
    • A porphyrin compound of the formula: ##STR1## wherein R.sub.1 and R.sub.2 are each --CH.dbd.CH.sub.2, --CH.sub.2 CH.sub.3, --CH(O-lower alkanoyl)CH.sub.3, --CH(OR)CH.sub.3 or --CH(O-lower alkylene-OR)CH.sub.3 ; R.sub.3 is --H, --COOH, --COO-lower alkyl, --COO-lower alkylene-OR or --COO-lower alkylene-OOC-Z; R.sub.4 is --H, -lower alkyl or -lower alkylene-OR; R is --H, -lower alkyl or a residue of a polyfunctional carboxyl compound excluding a hydrogen atom therefrom; Z is a residue of the compound of the formula (I) excluding R.sub.3 therefrom; A is --CH.sub.2 -- or --CO--; and the dotted line from the gamma-position indicates no bonding or a single direct bond; and the dotted line between the 7- and 8-positions indicates the presence of a single bond or a double bond; and its complexes with a metal(s) in the porphine skeleton and/or at the residue of the polyfuntional carboxyl compound, at least one of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 being a group containing R which represents the residue of the polyfunctional carboxyl compound and R.sub.1 being capable of representing 1-iodoethyl in addition to said meanings when R.sub.3 is --COO-lower alkylene-OOC-Z, which shows a high accumulation in the locus of cancer with quick excretion from normal tissues.
    • 一种下式的卟啉化合物:其中R 1和R 2各自为-CH = CH 2,-CH 2 CH 3,-CH(O-低级烷酰基)CH 3,-CH(OR)CH 3或-CH(O-低级) 亚烷基-OR)CH 3; R3是-H,-COOH,-COO-低级烷基,-COO-低级亚烷基-OR或-COO-低级亚烷基-OOC-Z; R4是-H-低级烷基或 - 低级亚烷基-OR; R是-H,低级烷基或除了氢原子以外的多官能羧基化合物的残基; Z是除了R3之外的式(I)化合物的残基; A是-CH2-或-CO-; 并且来自γ位置的虚线表示没有键合或单个直接键合; 7位和8位之间的虚线表示存在单键或双键; 其与卟啉骨架中的金属和/或多官能羧基化合物的残基的络合物,R 1,R 2,R 3和R 4中的至少一个为含有R的基团,其表示多官能羧基化合物的残基 当R 3为-COO-低级亚烷基-OOC-Z时,R 1除了所述含义之外,还能够表示1-碘乙基,其在正常组织中快速排出的癌症基因座中表现出高度的积累。